Kevetrin (the "flagship" CTIX compound) Summary:

Simply put, Kevetrin is a powerful compound that has so far shown astonishing results in lab testing against multiple different strains of treatment resistant, advanced stage cancers (lung, prostate, colon, pancreatic, etc. etc.)

Kevetrin is a small molecule that is different in structure from all currently marketed cancer drugs. It is water-soluble and simple to synthesize from commercially available starting materials

Kevetrin works by doing something no other drug has ever done before, activating the P53 gene, often called "the guardian angel of the human genome" - this is a potent cancer fighting gene that is deactivated or corrupted in over 50% of all cancer cases worldwide, regardless of cancer type

It is important to note, that this is a cancer drug that is revolutionary, not evolutionary - as it is an entirely new and novel type of treatment that has never been used in this medical capacity before

Kevetrin essentially gives your body a "genetic rebuild" to a degree, re-activating the powerful P53 gene that is active and working properly in the average healthy person

Researchers have been trying to accomplish this feat for decades – spending hundreds of millions of dollars in the process – only to come up short

Kevetrin is the first known non-geno toxic cancer drug that successfully activates the P53 gene as the mechanism of action – it has demonstrated that it can finally do what researchers have failed to accomplish for so long